// App-Quantinova.ai

: FK506-binding protein 11, a novel plasma cell specific antibody folding catalyst, is increased in idiopathic pulmonary fibrosis

Researchers

Presenter

  • Stefan Preisendörfer

Principal Investigators

  • Larissa Knüppel

  • Isis Fernandez

  • Leonhard Binzenhöfer

  • Brenda Juan-Guardela

  • Elisabeth Hennen

  • Clemens Ruppert

  • Andreas Guenther

  • Nikolaus Kneidinger

  • Marion Frankenberger

  • Rudolph Hatz

  • Jürgen Behr

  • Aloys Schepers

  • Anne Hilgendorff

  • Naftali Kaminski

  • Hans-Peter Bächinger

  • Oliver Eickelberg

  • Claudia Staab-Weijnitz

Medical Centers

  • Comprehensive Pneumology Center, Helmholtz Zentrum München, Munich, Germany,

  • Department of Neurology, University of California, San Francisco, United States

  • Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, Yale, United States of America

  • Department of Internal Medicine, Med. Klinik II, Universitätsklinikum Gießen, Gießen, Germany

  • Medizinische Klinik und Poliklinik IV, Renal Division, Klinikum der Ludwig Maximilians Universitaet, Munich, Germany

  • Asklepios-Fachkliniken Munchen-Gauting, Gauting, Germany

  • Monoclonal Antibody Core Unit & Research Group, Institute for Diabetes and Obesity, Helmholtz-Zentrum München, München, Germany,

  • Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, United States of America

  • Munich, Germany, Pulmonary and Critical Care Medicine University, Colorado Anschutz Medical Campus, Denver, Colorado, United States of America

Locations

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • FKBP prolyl isomerase 11

Drug/Treatment

  • Tacrolimus

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved